The Science Behind Reverse Aging with NAD+ and Sirtuin Activation

Pinnacle of Reverse Aging and Ageless Living : NAD+and Sirtuin Activation

NAD+and Sirtuin

The Aging Puzzle Unveiled

Sirtuins and the Cellular Symphony

NAD+and Sirtuin

The NAD+ Deficiency Conundrum

Unraveling the Research

A wealth of scientific studies supports the notion that maintaining optimal NAD+ levels could be a game-changer in the battle against aging. From mouse studies showcasing improved lifespan to human trials demonstrating enhanced cellular function, the evidence is compelling.

Strategies to Boost NAD+

Debunking Myths and Addressing Concerns

Embracing a Healthier, Youthful Future


Guarente L. (2013). Calorie restriction and sirtuins revisited. Genes & Development, 27(19), 2072–2085.

Imai, S., & Guarente, L. (2014). NAD+ and sirtuins in aging and disease. Trends in Cell Biology, 24(8), 464–471.

Mouchiroud, L., & Auwerx, J. (2011). NAD+ metabolism: a therapeutic target for age-related metabolic disease. Critical Reviews in Biochemistry and Molecular Biology, 48(4), 397–408.

Gomes, A. P., et al. (2013). Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell, 155(7), 1624–1638.

Bogan, K. L., & Brenner, C. (2008). Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annual Review of Nutrition, 28, 115–130.

Satoh, A., et al. (2013). Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metabolism, 18(3), 416–430.

Fang, E. F., et al. (2016). NAD+ replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA repair. Cell Metabolism, 24(4), 566–581

Bonkowski, M. S., & Sinclair, D. A. (2016). Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds. Nature Reviews Molecular Cell Biology, 17(11), 679–690.

Rajman, L., et al. (2018). CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metabolism, 27(4), 1084–1096.

Yoshino, J., et al. (2011). Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metabolism, 14(4), 528–536.

6 thoughts on “The Science Behind Reverse Aging with NAD+ and Sirtuin Activation

Leave a Reply

Your email address will not be published. Required fields are marked *

Follow by Email
Post on X